213 related articles for article (PubMed ID: 37898399)
1. ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification.
Rouleau-Turcotte É; Pascal JM
J Biol Chem; 2023 Dec; 299(12):105397. PubMed ID: 37898399
[TBL] [Abstract][Full Text] [Related]
2. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
[TBL] [Abstract][Full Text] [Related]
3. PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites.
Lin X; Jiang W; Rudolph J; Lee BJ; Luger K; Zha S
Nucleic Acids Res; 2022 Apr; 50(7):3958-3973. PubMed ID: 35349716
[TBL] [Abstract][Full Text] [Related]
4. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging.
Zhang H; Lin X; Zha S
Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996
[TBL] [Abstract][Full Text] [Related]
5. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.
Zentout S; Imburchia V; Chapuis C; Duma L; Schützenhofer K; Prokhorova E; Ahel I; Smith R; Huet S
Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322689121. PubMed ID: 38865276
[TBL] [Abstract][Full Text] [Related]
6. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
[TBL] [Abstract][Full Text] [Related]
7. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
Matkarimov BT; Zharkov DO; Saparbaev MK
Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
[TBL] [Abstract][Full Text] [Related]
9. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
[TBL] [Abstract][Full Text] [Related]
10. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
[TBL] [Abstract][Full Text] [Related]
11. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3.
Richards F; Llorca-Cardenosa MJ; Langton J; Buch-Larsen SC; Shamkhi NF; Sharma AB; Nielsen ML; Lakin ND
Nat Commun; 2023 Jul; 14(1):4310. PubMed ID: 37463936
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
15. PARP mediated DNA damage response, genomic stability and immune responses.
Zong C; Zhu T; He J; Huang R; Jia R; Shen J
Int J Cancer; 2022 Jun; 150(11):1745-1759. PubMed ID: 34952967
[TBL] [Abstract][Full Text] [Related]
16. PARP2 Is the Predominant Poly(ADP-Ribose) Polymerase in Arabidopsis DNA Damage and Immune Responses.
Song J; Keppler BD; Wise RR; Bent AF
PLoS Genet; 2015 May; 11(5):e1005200. PubMed ID: 25950582
[TBL] [Abstract][Full Text] [Related]
17. The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks.
Blessing C; Mandemaker IK; Gonzalez-Leal C; Preisser J; Schomburg A; Ladurner AG
Mol Cell; 2020 Dec; 80(5):862-875.e6. PubMed ID: 33275888
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
Hopkins TA; Shi Y; Rodriguez LE; Solomon LR; Donawho CK; DiGiammarino EL; Panchal SC; Wilsbacher JL; Gao W; Olson AM; Stolarik DF; Osterling DJ; Johnson EF; Maag D
Mol Cancer Res; 2015 Nov; 13(11):1465-77. PubMed ID: 26217019
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]